Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable? - FiercePharma

Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?  FiercePharma

Less than a year after securing its first Chinese approval, in previously treated metastatic melanoma patients, Merck & Co.'s Keytruda has leaped ahead of ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...